Terlipressin saved the life of a child with severe nonvariceal upper gastrointestinal bleeding.

Erkek, NİLGÜN; Senel, Saliha; Hizli, Samil; Karacan, Can

doi:10.1016/j.ajem.2010.02.010

Terlipressin saved the life of a child with severe nonvariceal upper gastrointestinal bleeding.

Erkek N., Senel S., Hizli S., Karacan C. D.

The American journal of emergency medicine, cilt.29, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 29
Basım Tarihi: 2011
Doi Numarası: 10.1016/j.ajem.2010.02.010
Dergi Adı: The American journal of emergency medicine
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Akdeniz Üniversitesi Adresli: Hayır

Özet

Terlipressin is a longer half-life synthetic analogue of vasopressin. Its use is approved in esophageal variceal bleedings as an adjuvant therapy. The beneficial effects of terlipressin use in children with septic shock had also been revealed. We described a 10-month-old boy with massive, life-threatening, nonvariceal upper gastrointestinal bleeding rescued with terlipressin therapy. To our knowledge, this is the first report of terlipressin use in a child with nonvariceal upper gastrointestinal bleeding. It might be useful as rescue therapy in refractory cases of nonvariceal upper gastrointestinal bleeding when surgery or endoscopic procedures could not be performed.